Randomized trial investigates vitamin D3 effects on steroidogenesis in periovarian adipose tissue of rats with PCOS, suggesting enhanced ovarian function.
This study investigated the effect of vitamin D 3 on polycystic ovary syndrome (PCOS) characteristics, as well as on periovarian adipose tissue (POAT) morphology and function, through the expression of key molecules involved in steroidogenesis in a letrozole-induced rat model of PCOS. Over a 21-day experimental period, 32 female Wistar rats were randomly assigned to four groups (n=8 per each group): control (C), vitamin D 3 -supplemented (VD), letrozole-treated to induce PCOS (L), and letrozole plus vitamin D 3 -treated (VD+L). PCOS induction was confirmed in the L group by increased body weight, acyclicity, ovarian cyst formation, and hyperandrogenism. Following vitamin D 3 treatment, single antral follicles in the ovary and a few nucleated epithelial cells in vaginal smears were observed in the VD+L group. The induction of PCOS increased the average size of periovarian adipocytes, whereas vitamin D 3 reversed this effect. Regarding the effect of vitamin D 3 on steroidogenesis in POAT, mRNA transcript and protein abundances of StAR protein and CYP17A1 were unchanged among groups. A decrease in CYP11A1 protein abundance was noted in the L and VD+L groups, alongside reduced 3βhsd transcript level. However, vitamin D 3 exerted the most pronounced effect on CYP19A1 expression, with significantly greater mRNA and protein abundances in the VD+L group than in the L group, suggesting enhanced 17β-estradiol synthesis. Overall, these findings highlight the crucial role of vitamin D 3 in modulating POAT steroidogenesis, which may in turn impact ovarian function and improve reproductive parameters in PCOS.
No takes yet. Share an insight, caveat, or question.
Szyrzisko et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: